{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:14:41Z","timestamp":1781896481694,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22477075"],"award-info":[{"award-number":["22477075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077078"],"award-info":[{"award-number":["22077078"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2025.117237","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:44:57Z","timestamp":1736037897000},"page":"117237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of proteolytically stable monocyte locomotion inhibitory factor peptide through systematic structural optimization"],"prefix":"10.1016","volume":"285","author":[{"given":"Yajing","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1648-0833","authenticated-orcid":false,"given":"Yejiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117237_bib1","first-page":"S230","article-title":"The economic burden of osteoarthritis","volume":"15","author":"Bitton","year":"2009","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ejmech.2025.117237_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/annrheumdis-2019-216515","article-title":"Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017","volume":"79","author":"Safiri","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2025.117237_bib3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/ard.48.11.958","article-title":"Osteoarthritis: the cause not result of joint failure?","volume":"48","author":"Hutton","year":"1989","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2025.117237_bib4","doi-asserted-by":"crossref","first-page":"ix","DOI":"10.1016\/j.rdc.2013.03.006","article-title":"The use of imaging in inflammatory joint and vascular disorders","volume":"39","author":"Weisman","year":"2013","journal-title":"Foreword, Rheum Dis. Clin. North Am."},{"key":"10.1016\/j.ejmech.2025.117237_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/phar.1646","article-title":"Risk of acute cerebrovascular and cardiovascular events among users of acetaminophen or an acetaminophen-codeine combination in a cohort of patients with osteoarthritis: a nested case-control study","volume":"35","author":"Roberto","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejmech.2025.117237_bib6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.joca.2016.12.025","article-title":"Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study","volume":"25","author":"Wang","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ejmech.2025.117237_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14656566.2017.1414802","article-title":"Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage","volume":"19","author":"Maniar","year":"2018","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117237_bib8","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/DDDT.S295224","article-title":"The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date","volume":"15","author":"Oo","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2025.117237_bib9","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s12276-021-00710-y","article-title":"Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions","volume":"53","author":"Cho","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117237_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1185\/03007995.2013.855184","article-title":"NSAID-sparing effect of glucosamine hydrochloride in patients with knee osteoarthritis: an analysis of data from a French database","volume":"30","author":"Bertin","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejmech.2025.117237_bib11","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","article-title":"Oral delivery of proteins and peptides: challenges, status quo and future perspectives","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117237_bib12","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.drudis.2021.01.022","article-title":"Converting peptides into drugs targeting intracellular protein-protein interactions","volume":"26","author":"Philippe","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.117237_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.117237_bib14","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1021\/jacs.4c00314","article-title":"Inverse peptide synthesis using transient protected amino acids","volume":"146","author":"Liu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117237_bib15","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1161\/STROKEAHA.112.657908","article-title":"A pentapeptide monocyte locomotion inhibitory factor protects brain ischemia injury by targeting the eEF1A1\/endothelial nitric oxide synthase pathway","volume":"43","author":"Zhang","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2025.117237_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-3024.2003.00657.x","article-title":"An anti-inflammatory oligopeptide produced by Entamoeba histolytica down-regulates the expression of pro-inflammatory chemokines","volume":"25","author":"Utrera-Barillas","year":"2003","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ejmech.2025.117237_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2017.03.020","article-title":"Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species","volume":"104","author":"Jensen","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.117237_bib18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1021\/acschembio.9b00234","article-title":"Discovery of peptide antibiotics composed of d-amino acids","volume":"14","author":"Adaligil","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117237_bib19","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1016\/j.apsb.2023.05.004","article-title":"Discovery of an orally effective double-stapled peptide for reducing ovariectomy-induced bone loss in mice","volume":"13","author":"Cong","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117237_bib20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s40262-015-0343-6","article-title":"Liraglutide in type 2 diabetes mellitus: clinical pharmacokinetics and pharmacodynamics","volume":"55","author":"Jacobsen","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2025.117237_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0141-0229(03)00160-1","article-title":"Enzyme stabilization\u2014recent experimental progress","volume":"33","author":"\u00d3\u2019F\u00e1g\u00e1in","year":"2003","journal-title":"Enzym. Microb. Technol."},{"key":"10.1016\/j.ejmech.2025.117237_bib22","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1038\/s41467-023-42342-y","article-title":"N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevity","volume":"14","author":"Varland","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117237_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0116-z","article-title":"Spotlight on protein N-terminal acetylation","volume":"50","author":"Ree","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117237_bib24","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1093\/hmg\/ddu611","article-title":"Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects","volume":"24","author":"Myklebust","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2025.117237_bib25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.1183147","article-title":"N-terminal acetylation of cellular proteins creates specific degradation signals","volume":"327","author":"Hwang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.117237_bib26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/la103800h","article-title":"Effect of poly(ethylene glycol) (PEG) spacers on the conformational properties of small peptides: a molecular dynamics study","volume":"27","author":"Xue","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.ejmech.2025.117237_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00011-010-0261-x","article-title":"Anti-inflammatory defense mechanisms of Entamoeba histolytica","volume":"60","author":"Silva-Garc\u00eda","year":"2011","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2025.117237_bib28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.molcel.2013.03.018","article-title":"Control of protein quality and stoichiometries by N-terminal acetylation and the N-end rule pathway","volume":"50","author":"Shemorry","year":"2013","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejmech.2025.117237_bib29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1105\/tpc.15.00173","article-title":"Two N-terminal acetyltransferases antagonistically regulate the stability of a nod-like receptor in Arabidopsis","volume":"27","author":"Xu","year":"2015","journal-title":"Plant Cell"},{"key":"10.1016\/j.ejmech.2025.117237_bib30","article-title":"N-terminal acetylation of antimicrobial peptide L163 improves its stability against protease degradation","volume":"27","author":"Li","year":"2021","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ejmech.2025.117237_bib31","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1016\/S0021-9258(17)40291-2","article-title":"Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117237_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0169-409X(02)00027-3","article-title":"Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications","volume":"54","author":"Wang","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2025.117237_bib33","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117237_bib34","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1089\/107999001317205240","article-title":"Structural and biologic characterization of pegylated recombinant IFN-alpha2b","volume":"21","author":"Grace","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.ejmech.2025.117237_bib35","first-page":"315","article-title":"Immunotherapy with monomethoxypolyethylene glycol modified allergens","volume":"6","author":"Dreborg","year":"1990","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejmech.2025.117237_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/ja00055a010","article-title":"Structures of sweet and bitter peptide diastereomers by NMR, computer simulations, and x-ray crystallography","volume":"115","author":"Goodman","year":"1993","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117237_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1006\/bbrc.1997.7855","article-title":"Amino acids and peptides. XXXII: a bifunctional poly(ethylene glycol) hybrid of fibronectin-related peptides","volume":"241","author":"Maeda","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.117237_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0167-4838(84)90268-1","article-title":"Physicochemical and biological properties of poly(ethylene glycol)-coupled immunoglobulin G","volume":"788","author":"Suzuki","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2025.117237_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000469036","article-title":"Catalytic activity of administered gulonolactone oxidase polyethylene glycol conjugates","volume":"42","author":"Hadley","year":"1989","journal-title":"Enzyme"},{"key":"10.1016\/j.ejmech.2025.117237_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.1988.tb25837.x","article-title":"Lipase modified for solubility in organic solvents","volume":"542","author":"Baillargeon","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.117237_bib41","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S0188-4409(00)00164-8","article-title":"The effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon nitric oxide production by human leukocytes","volume":"31","author":"Rico","year":"2000","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ejmech.2025.117237_bib42","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.4049\/jimmunol.148.12.3999","article-title":"Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine","volume":"148","author":"Lin","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2025.117237_bib43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1749-6632.1990.tb18201.x","article-title":"Chemical modification of enzyme molecules to improve their characteristics","volume":"613","author":"Cao","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.117237_bib44","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1016\/S0021-9258(18)68146-3","article-title":"Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers","volume":"263","author":"Knauf","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117237_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1247\/csf.17.157","article-title":"Chemical modification of recombinant human granulocyte colony-stimulating factor by polyethylene glycol increases its biological activity in vivo","volume":"17","author":"Satake-Ishikawa","year":"1992","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.ejmech.2025.117237_bib46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0142-9612(00)00193-9","article-title":"Peptide and protein PEGylation: a review of problems and solutions","volume":"22","author":"Veronese","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2025.117237_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/psc.3293","article-title":"d-Amino acid substitutions and dimerization increase the biological activity and stability of an IL-15 antagonist peptide","volume":"27","author":"Rodr\u00edguez-\u00c1lvarez","year":"2021","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ejmech.2025.117237_bib48","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s10067-015-2953-7","article-title":"Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients","volume":"34","author":"Morin","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.ejmech.2025.117237_bib49","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2025.117237_bib50","doi-asserted-by":"crossref","first-page":"16346","DOI":"10.1021\/ja907150m","article-title":"A convenient catalyst for aqueous and protein Suzuki-Miyaura cross-coupling","volume":"131","author":"Chalker","year":"2009","journal-title":"J. Am. Chem. Soc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:45:49Z","timestamp":1740375949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":50,"alternative-id":["S0223523425000029"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117237","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of proteolytically stable monocyte locomotion inhibitory factor peptide through systematic structural optimization","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117237"}}